Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the ...
RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...
A research team consisting of Professor Dong Sung Kim, Professor Anna Lee, and Dr. Jaeseung Youn from the Department of ...
When studying the spread of cancer or the behavior of a virus like the one that causes COVID-19, the irony is that working ...
Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.
All complex life on Earth, including plants and animals, are made up of eukaryotic cells, which are more sophisticated than ...
Cells were divided into six groups ... And then the PCR products were cloned into p3XFLAG-CMV-14 at BamHI and EcoRV sites. The respective FLAG-fusion fragments were then cloned into pLVX-IRES-puro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback